Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Subst Use Misuse. 2015 Jan 5;50(5):566–581. doi: 10.3109/10826084.2014.991405

Determining Smoking Cessation Related Information, Motivation, and Behavioral Skills among Opiate Dependent Smokers in Methadone Treatment

Nina A Cooperman 1, Kimber P Richter 2, Steven L Bernstein 3, Marc L Steinberg 4, Jill M Williams 5
PMCID: PMC4646090  NIHMSID: NIHMS702045  PMID: 25559697

Abstract

Background

Over 80% of people in methadone treatment smoke cigarettes, and existing smoking cessation interventions have been minimally effective.

Objective

To develop an Information-Motivation-Behavioral Skills (IMB) Model of behavior change based smoking cessation intervention for methadone maintained smokers, we examined smoking cessation related information, motivation, and behavioral skills in this population.

Methods

Current or former smokers in methadone treatment (n=35) participated in focus groups. Ten methadone clinic counselors participated in an individual interview. A content analysis was conducted using deductive and inductive approaches.

Results

Commonly known information, motivation, and behavioral skills factors related to smoking cessation were described. These factors included: the health effects of smoking and treatment options for quitting (information); pregnancy and cost of cigarettes (motivators); and coping with emotions, finding social support, and pharmacotherapy adherence (behavioral skills). Information, motivation, and behavioral skills factors specific to methadone maintained smokers were also described. These factors included: the relationship between quitting smoking and drug relapse (information), the belief that smoking is the same as using drugs (motivator); and coping with methadone clinic culture and applying skills used to quit drugs to quitting smoking (behavioral skills). Information, motivation, and behavioral skills strengths and deficits varied by individual.

Conclusions

Methadone maintained smokers could benefit from research on an IMB Model based smoking cessation intervention that is individualized, addresses IMB factors common among all smokers, and also addresses IMB factors unique to this population.

Keywords: methadone, smoking cessation, opiate, cigarette, Information-Motivation-Behavioral Skills Model


Over 80% of people in methadone treatment for opiate dependence smoke cigarettes, few receive help quitting, and many will ultimately die from untreated tobacco dependence (Hurt et al., 1996; Nahvi, Richter, Li, Modali, & Arnsten, 2006; Richter, Ahluwalia, Mosier, Nazir, & Ahluwalia, 2002; Richter, Choi, McCool, Harris, & Ahluwalia, 2004). Studies of smoking cessation interventions among smokers in methadone treatment have found that, in most studies, the percentage of individuals who quit smoking was small and nearly all quickly returned to smoking (Campbell, Wander, Stark, & Holbert, 1995; Nahvi, Ning, Segal, Richter, & Arnsten, 2014; Reid et al., 2008; Richter & Arnsten, 2006; Richter, McCool, Catley, Hall, & Ahluwalia, 2005; Schmitz, Grabowski, & Rhoades, 1994; Shoptaw et al., 2002; Stein et al., 2013; Stein et al., 2006). However, most smoking cessation interventions investigated in methadone treatment do not account for the complex issues prevalent among people with opiate dependence. A new smoking cessation intervention based on the Information-Motivation-Behavioral Skills (IMB) Model of behavior change could better address these complex issues, allow for tailoring of the intervention to the unique needs of the individual, and be more effective than previously studied interventions among methadone maintained smokers. Therefore, as the first step in the development of an IMB Model based smoking cessation intervention for methadone maintained smokers, we utilized qualitative research methods to explore smoking cessation related information, motivation, and behavior skills among opiate dependent smokers in methadone treatment.

The IMB Model asserts that health-related information, motivation, and behavioral skills are all necessary for health behavior change (Fisher, Fisher, & Harman). While information and motivation primarily work through behavioral skills to affect behavior, both information and motivation can also directly influence behavior. When each of these pieces of the model is in place, desired health behavior changes are more likely to occur; however, when any component of the model is missing or inadequate in relation to a desired behavior change, the change will be less likely to happen. To date, smoking cessation intervention research among substance abusers, including among opiate dependent smokers in methadone treatment, have examined treatments that have focused on only one or two, if any, of the components of the IMB model, and an intervention based on all of the IMB model components could be better tailored to the individual and more effective.

IMB-inspired interventions have demonstrated efficacy in changing behavior among substance abusers and across a variety of health behaviors, but the IMB model has yet to be applied to smoking cessation intervention (Cooperman, Parsons, Chabon, Berg, & Arnsten, 2007; Fisher, et al., 2009). In the context of smoking cessation for any population, examples of information needed to quit would include knowledge about the negative impact of smoking on health, resources for smoking cessation support, and options for pharmacotherapy (Bansal, Cummings, Hyland, & Giovino, 2004; Biener, Bogen, & Connolly, 2007; Hyland et al., 2006; Li et al., 2010; Li et al., 2011; Schauer, Malarcher, Zhang, Engstrom, & Zhu, 2013; Vogt, Hall, & Marteau, 2008; Zhu et al., 2002). Motivation to quit is influenced by factors such as experiencing the health consequences of smoking and confidence in ability to quit (Borland et al., 2010; McCaul et al., 2006). Many behavioral skills are necessary for smoking cessation to occur, and lack of skills are often the reason why motivated individuals are not able to quit (Kennett, Morris, & Bangs, 2006). To quit smoking one needs to be able to properly utilize pharmacotherapy, cope with stress, identify and avoid triggers, find support, deal with co-morbid conditions, and manage cravings (Axelrod, 1991; Catz et al., 2011; Cook et al., 2014; Ferguson & Shiffman, 2009; Lawhon, Humfleet, Hall, Munoz, & Reus, 2009; Tsourtos & O’Dwyer, 2008; Yong & Borland, 2008).

The first step in the IMB approach to developing health behavior interventions is to determine the specific information, motivation, and behavior skills that are relevant for a particular health behavior and population through elicitation research (Fisher, et al.). Therefore, we conducted focus groups with methadone maintained current and former smokers and individual interviews with methadone clinic counselors to determine the information deficits and strengths, levels of motivation, motivators and barriers to motivation, and behavioral skill deficits and strengths that could impact methadone maintained smokers ability to quit smoking and could be incorporated into an IMB based smoking cessation intervention for smokers in methadone treatment.

Methods

Procedures

Current and former smokers in methadone maintenance treatment (clients) were recruited in two urban methadone clinic waiting areas to participate in one of five focus groups (n=35 clients). To participate in the study, clients needed to be: (1) English speaking; (2) able to give informed consent; (3) not obviously under the influence of drugs or alcohol; (4) willing to be audio recorded; and, (5) have smoked 100 or more cigarettes during their lifetime. Since we were able to identify and recruit only three former smokers to participate in the study, they were integrated into the focus groups with current smokers. After informed consent, participants completed a demographic questionnaire. The group discussion was facilitated by two, trained facilitators with a discussion guide. Facilitators asked, with open ended questions, about smoking history and behavior, knowledge of and experiences with smoking cessation treatment and pharmacotherapy, skills and knowledge necessary for quitting, motivation to quit smoking, the relationships between drug use and methadone treatment and smoking, and potential smoking cessation treatment barriers. For example, focus group participants were instructed to, “Tell me about your smoking,” and were asked open-ended questions, such as, “What makes it difficult to quit cigarette smoking?” and “How does smoking fit into your recovery?” Focus groups with participants who quit smoking or made a quit attempt were asked about motivating factors for quit attempts, quitting experiences, skills and knowledge necessary for quitting, reasons for relapse after quitting, and obstacles to long-term abstinence after quitting. For example, participants who made a quit attempts were asked, “How is quitting smoking similar or different from quitting drugs?” Facilitators did not ask specifically about known or theorized barriers to smoking cessation. Groups were audio recorded and lasted for approximately 1.5 to 2 hours. Participants received a $15 gift card for their time. Focus groups were conducted until theoretical saturation was reached--where no new domains, concepts, or dimensions were being discovered, and we began to record similar comments/themes in response to interview questions (Glaser & Strauss, 1967; Strauss & Corbin, 1998).

Substance abuse counselors were recruited from the same clinics as the clients, during staff meetings, to participate in an individual interview (n=10 counselors). A trained interviewer conducted individual interviews with counselors. To participate in the study, substance abuse counselors must have worked clinically with methadone maintained clients for six or more months and be willing to be audio recorded. Before the interview, the counselors provided informed consent and completed a demographic questionnaire. The interview was facilitated with an interview guide. Counselors were asked about their perceptions of clients’ smoking habits, motivation to quit smoking, knowledge about quitting and smoking risks, skills needed for quitting, obstacles to quitting, and barriers to long-term abstinence. Interviews were audio recorded and lasted for approximately 60 to 90 minutes. Counselor interviews were conducted until theoretical saturation was reached. This study protocol was approved by the Rutgers Health Sciences Institutional Review Board.

Analyses

Demographic data were analyzed quantitatively with SPSS Version 21. We conducted a content analysis, using deductive and inductive approaches, to analyze qualitative data (Elo & Kyngas, 2008). Audio recordings were transcribed, and transcribed audio recordings were coded and analyzed using Atlas ti 6.2, qualitative data analysis software. We developed a categorization matrix (including strengths and deficits in information/knowledge, levels of motivation, motivators and barriers to motivation, and behavioral skill strengths and deficits) and used a deductive approach to code data according to the IMB Model of behavior change. Matrix subthemes and categories of information, motivation, and behavioral skills that were not in the initial matrix were analyzed inductively. Data analyzed inductively was “open coded:” identifying within the text key words, themes, and descriptions of behavior (Glaser & Strauss, 1967; Strauss & Corbin, 1998). Subsequently, these themes were grouped into coding categories and a code map was developed which allowed us to categorize and retrieve participant comments. Two observers coded 10% of data, and had excellent inter-observer agreement (Landis & Koch, 1977). Percentage agreement among all codes was 81%, with a kappa score of 0.80. A finalized codebook was determined, based on agreement between the two observers, and the remaining data was coded, by one observer, with the finalized codebook.

Results

Participants

The clients (n=35) had a median age of 46 (IQR 39–51), and 54% were female. Sixty-five percent were White, 29% Black, and 9% Hispanic. Seventy-nine percent completed high school. Among the substance abuse counselors (n=10), the median age was 46 (IQR 35–58). Seventy percent of the counselors were female; 70% were White, 20% were Hispanic, and, 20% were Black. Ninety percent of the counselors worked with methadone maintained clients for 2 or more years.

Information strengths and deficits

The clients and counselors described strengths and deficits in knowledge among clients that fit into three basic categories: 1) health, 2) treatment, and 3) drug relapse risk (Table 1).

Table 1.

Information strengths and deficits

Category Strength/
Deficit
Total
na
Clients
na
Client Examples Counselors
na
Counselor Examples
Health
Health effects
of smoking
Strength 7 5 “If you smoke you have a
higher risk of breast cancer,
lung cancer…all kinds
of cancers and heart attack… but
you still smoke. It’s like
we know the dangers and we
know we are killing
ourselves.”
2 “I think they have some
knowledge of it [the health effects
of smoking], and they choose to
ignore that.”
Deficit 11 6 “…I did not know anything
about smoking. It made me
feel good and that was it. I
never knew about all of the
hidden dangers which I am
trying to learn now.”
5 “They don’t see it as a cigarette is
a drug. It’s like water. It’s
acceptable. ‘I can drink water. It’s
not going to kill me.’”
Toxins in
cigarettes
Strength 1 1 “Like rat poisoning…all that
kind of stuff. I mean, there is
everything in cigarettes.”
0
Deficit 4 3 “I have a question…there is
still enough hazardous…what
is the word I am looking
for…leftovers? The toxins on
the clothes…that could affect
a child or baby?”
1 Clients need “more education, I
guess, on how it [smoking]
affects the body. Or what really
makes up a cigarette.”
Treatment
Pharmacoherapy Strength 22 15 “I know that there is a nicotine
patch and that there is a gum.”
7 “I know a few of them have said
they tried the patch or the gum.”
Deficit 16 11 “I didn’t even know Chantix
existed. Does that contain
nicotine?”
5 “A lot of them really do not want
to take any medications because
they are misinformed.”
Smoking
cessation
counseling
resources
Strength 8 6 “I know that there is a help for
quitting hotline.” (Client)
2 “I have had a couple of people
say that they have gone to a quit
center.”
Deficit 3 2 “I don’t know [about any
options for getting help to quit
smoking].”
1 “I think there is a lack of
awareness about it. Not
everybody knows about the quit
center that was there.”
Drug relapse risk
The
relationship
between
quitting
smoking and
drug relapse
Strength 0 0 0
Deficit 5 5 “I think, in some peoples’
cases, smoking and drinking
helps them stay clean.”
0
a

Number of participants who provided comments.

Health

Five clients knew that smoking is bad for their health and about the toxins in cigarette smoke; however, 6 clients expressed a lack of knowledge or had questions about the health effects of smoking and toxins in cigarettes. Although a couple of counselors reported that clients had an awareness of the health effects of smoking, five reported that their clients had deficits in knowledge about the health risks of smoking and toxins in cigarettes.

Treatment

More clients and counselors reported an awareness of pharmacotherapy or counseling options for quitting smoking among clients than reported knowledge deficits. However, 11 clients did express lack of knowledge or misconceptions about smoking cessation pharmacotherapy or counseling options, and this lack of knowledge was supported by several counselors. For example, some clients wondered about how long nicotine replacement therapy is taken or feared that if they smoked on the patch they “might have a heart attack.”

Drug relapse risk

Five clients believed that quitting smoking could lead to a drug relapse due to previous experiences quitting smoking, relapsing to smoking, and then relapsing to drug use. In other words, they believed that quitting smoking as opposed to relapsing back to smoking was related to drug use; therefore, they should not quit smoking. Three clients believed that that smoking cigarettes is “better than using drugs” because “it’s legal” or because “I don’t do anything else.”

Motivation

Six clients made statements indicating readiness to quit smoking, and 2 clients expressed confidence in their ability to quit; however, 11 clients made statements that reflected lack of motivation or ambivalence about quitting and 4 clients made statements about low confidence in ability to quit. A client that was clearly not ready to quit smoking said, “I don’t care if it is going to cause me cancer.” An ambivalent client stated, “I want it, but I don’t want it.” A client who lacked confidence in his ability to quit smoking stated, “I’m afraid to quit because I am afraid I won’t succeed.” The counselor comments echoed the client’s statements that a few clients are ready to quit smoking, some are not ready to quit smoking, and many are ambivalent. Also, 3 counselors spoke about clients’ lack of confidence in their ability to quit smoking, while none of the counselors mentioned high levels of client confidence in ability to quit smoking.

Motivators

The clients and counselors described five factors that could act as motivators for clients to quit smoking: 1) pregnancy or children, 2) the cost of smoking, 3) physical health, 4) the smell of cigarette smoke, and 5) the belief that smoking is the same as using drugs (Table 2). Clients and counselors described how each factor acted as a motivator for some clients, and for other clients, either the factor wasn’t present or, when the factor was present, did not act as a motivator.

Table 2.

Motivators and barriers to motivation

Category Motivator
(Barrier)/
Not
Motivator
(Barrier)
Total
na
Clients
na
Client Examples Counselors
na
Counselor Examples
Motivators
Pregnancy/
Children
Motivator 5 3 “I have a daughter, so, you
know, it is important that I
do quit. I want to be around
to see her grow up and
become a teenager and get
married.”
2 “Some of them have
families and maybe want to
be around more for their
families. They’re just
motivated better. They’re
more motivated.”
Not
Motivator
4 4 “I smoked more, for some
reason, when I was
pregnant.”
0
Cost of
smoking
Motivator 5 2 “The only reason why I try
to cut down is because they
are so expensive.”
3 “My client…she rolls her
own cigarettes to cut down
the cost, but she is really
trying to quit.”
Not
Motivator
8 10 “I would scrounge every
penny I had in my house to
buy a pack of cigarettes if I
was in need of it. I have
done it before. Or borrow
money off of somebody if
you don’t have it…You do
anything to buy that pack of
cigarettes. Just like we
would have done anything
to buy our drugs.”
2 “They feel like it is a lesser
of the evils. Before I was
doing this, now I am
smoking cigarettes. Like,
‘Yeah, I don’t have a lot of
money, but that is better
than me popping ten bags at
$100. I am not robbing or
stealing for it.’”
Health Motivator 12 7 “You wake up in the
morning with a lot of
phlegm, and it is getting to
the point where I am sick
and tired of it.”
5 “They have health
repercussions, and the fact
that there is this co-
occurring addiction going
on, I think that is really
upsetting to them.”
Not
Motivator
14 8 “I had two heart attacks. I
had a heart attack in 2008
and another one in 2010,
this year, and I still smoke.”
6 “Right now it is not
bothering me, and I feel
fine.”
Smell of
smoke
Motivator 3 3 “I hate the smell in my in
my house, in my hair, in the
car. I just hate it all around.”
1 “I had a client here who
tried to stop and then we
made a rule. At the house,
people cannot smoke in the
house…Then we talked
about other things, like, it
makes the house stinky.”
Not
Motivator
3 3 “I love the smell of smoke. I
really do.”
0
Belief that
smoking is
the same as
using drugs
Motivator 5 3 “I am trying to stay clean…I
want to be clean from
everything.”
2 “They feel like they are
trying to give up an
addiction, trying to give up
heroin use or whatever, and
yet they are still
addicted…it is upsetting to
them…they still feel bad
that they are addicted to
something.”
Not
Motivator
10 3 “I don’t smoke pot
anymore. I really don’t
drink. I don’t do any drugs.
So like my cigarettes is like
the only thing that I really
have. You know and I
would rather go out and
smoke a cigarette than, you
know, smoke weed or, you
know, smoke something
else.”
8 “I think for some people, it
is seen as less of a drug
because it is legal, you can
go buy it. It is dangerous,
but you do not feel the
effects right away.”
Motivation Barriers
Enjoyment
of smoking
Motivation
Barrier
6 4 “The problem with me is
that I love to smoke. I love
the taste of it. I love holding
it. I love the feel of the
smoke, how it goes and fills
up your lungs and blowing
it out. I love the whole
process.”
2 “They love to smoke, and
they smoke often.”
Not
Motivation
Barrier
9 8 “I think it is disgusting. I am
even kind of embarrassed
sometimes, smoking.”
1 “He was just tired of
smoking…He had
mentioned in his treatment
plan one of his goals was to
quit smoking.”
Concern
about weight
gain
Motivation
Barrier
5 5 “Methadone makes you gain
weight and so does stopping
smoking. People would be
scared to gain weight on top
of that.”
0
Not
Motivation
Barrier
2 2 “I’d rather be fat than dead.” 0
Cost of
treatment
Motivation
Barrier
15 5 “When you are smoking and
you want to quit, and you
have to buy all that stuff. It
is, like, two. You are
spending money on both at
the same time…you are
spending double the
money…It’s like I am
spending so much…you’re
like ‘it’s not worth it’.
10 “They know about the gum
and the patches, but they
really cannot afford it.”
Not
Motivation
Barrier
2 1 “If the doctor wrote a
prescription, you could get
it for free.”
0
Feeling that
it is too
much to quit
smoking and
drugs at the
same time
Motivation
Barrier
11 4 “I would think that trying to
quit everything all at once
is detrimental.”
7 “They will tell you, ‘Yeah, I
gotta quit, but let me get
through this methadone
treatment, you know. I gotta
get other things in my life
together first.”
Not
Motivation
Barrier
6 4 “I would love to quit
everything all at once.”
2 There are “the people who
are trying to tackle it all at
once.”
Social
pressure to
smoke
Motivation
Barrier
10 5 “You are around people in
the clinic, and you are doing
groups with people in the
clinic, they smoke, you
smoke. I think a little bit of
it is peer pressure and group
dynamics”
5 “I think it is really hard for
them to comprehend
[quitting smoking]…I mean
most of them come from
families where everybody
smokes cigarettes.”
Not
Motivation
Barrier
3 3 “I was living with my
boyfriend for a little bit, and
his mom was very anti-
smoking…I didn’t really
like smoking around her, so
I really couldn’t smoke.”
0
a

Number of participants who provided comments.

Pregnancy or children

Reducing fetal harm when pregnant, protecting their children from secondhand smoke, and living to see their children grow is an important reason to quit smoking for some clients, according to 3 clients and 2 counselors. However, 4 clients reported continuing to smoke or lacking motivation to quit despite being pregnant or having children.

Cost of smoking

Two clients and 3 counselors reported that the expense of smoking acts as a motivator for cutting down, changing smoking habits, or quitting for some clients; however, 10 clients spoke about how they are aware of and disturbed by how much money they are spending on cigarettes, but continue to smoke despite the cost burden. To most clients who spoke about the cost of smoking, the craving for cigarettes overrode any concerns about cost.

Physical health

Physical health was the most common potential motivator for quitting smoking mentioned by both the clients and the counselors. Seven clients spoke about experiencing or anticipating the negative health effects of smoking which is positively impacting their desire to quit smoking. However, 8 clients and 6 counselors stated that many clients continue to smoke despite experiencing or knowledge about the negative health effects of smoking. Clients in the focus groups reported having heart disease, lung cancer, difficulty breathing, chest tightness, increased mucus, asthma, cough, and dizziness and continued smoking.

Smell of smoke

One counselor and 3 clients mentioned that the smell of cigarette smoke is aversive and a motivator for quitting, while 3 clients stated that they either like the smell of cigarettes or, despite not liking the smell, continue to smoke.

Belief that smoking is the same as using drugs

For 3 clients, the belief that smoking is as bad as using drugs is a motivator for quitting and they want to be “clean from everything,” including tobacco. However, according to most of the counselors and 3 clients, clients “see or perceive cigarette smoking as much less harmful than the drugs,” negatively impacting their motivation to quit smoking.

Barriers to Motivation

The clients and counselors also described five factors that could negatively influence clients’ motivation to quit smoking: 1) smoking enjoyment, 2) concern about weight gain, 3) the cost of smoking cessation treatment, 4) the feeling that it is too much to quit smoking and drugs at the same time, and 5) social pressure to smoke (Table 2). Clients and counselors also described how each factor acted as a barrier to motivation for some clients, and for other clients either the factor wasn’t present or, when the factor was present, did not negatively impact motivation.

Smoking enjoyment

A few clients and 2 counselors spoke about how they or their clients love smoking cigarettes; however, 8 clients stated that enjoyment is not a barrier to quitting motivation for them and that they “hate” or “can’t stand” smoking.

Concern about weight gain

Seven clients spoke about the potential for weight gain as a barrier to smoking cessation motivation. Although 2 clients stated that the idea of weight gain was not a deterrent to quitting smoking for them, five felt that concern about weight gain prevented them from wanting to quit smoking.

Cost of smoking cessation treatment

Both counselors and clients reported that lack of financial resources, lack of or inadequate health insurance, and the expense of smoking cessation pharmacotherapy and counseling negatively influenced motivation to quit among clients. Strengths and deficits in clients’ ability to manage finances to obtain pharmacotherapy are discussed in the “behavioral skills strengths and deficits” section.

The feeling that it is too much to quit smoking and drugs at the same time

The majority of counselors and 4 clients felt that quitting drugs and smoking at the same time is “too much” or “detrimental” for clients; yet, 4 clients and 2 counselors indicated that the process of quitting drugs is not a barrier to motivation and that “smoking is attached to the drugs…so anything that gives you a chance to relapse, a reason to use drugs, should be addressed.”

Social pressure to smoke

Three clients and 5 counselors spoke about how social pressure, either within the clinic or in clients’ other social networks, negatively impacts clients’ motivation to quit smoking. However, 3 clients described situations where social pressure to quit positively influenced their desire to stop smoking. Strengths and deficits in clients’ ability to negotiate clinic culture and develop social networks supportive of quitting are discussed in the “behavioral skills strengths and deficits” section.

Behavioral skills strengths and deficits

The clients and counselors described behavioral skills that impact clients’ ability to quit smoking that fall into five categories (Table 3). The categories are: 1) coping skills (i.e., replacing smoking, coping with emotions/stress, coping with cravings, and coping with fatigue), 2) social skills (i.e., negotiating clinic culture, developing supportive social networks, and saying “no” to offered cigarettes), 3) breaking links (with alcohol, coffee, methadone dosing, and drugs) and changing routine, 4) taking and obtaining pharmacotherapy, and 5) applying existing skills.

Table 3.

Behavioral skills strengths and deficits

Definition/
Code
Strength/
Deficit
Total
na
Clients
na
Client Examples Counselors
na
Counselor
Examples
Coping skills
Replacing
smoking
(“smoking
is all I
have”)
Strength 4 4 “It seems like I can pick it
up…I can do without. I can
take it or leave it.”
0
Deficit 16 8 “I feel like if I quit smoking,
what am I going to replace
that [with]? I don’t want to
replace it with eating because I
don’t want to get fat. I don’t
know what else I would
replace it with.”
8 “…if you are going to take
something away, you have
to give something in its
place.”
Coping
with
emotions/
stress
Strength 4 4 “It’s always weirded me out
that when people are nervous,
they chain smoke. I cannot do
that because if I am nervous
and I start chain smoking, I get
more nervous.”
0
Deficit 21 13 “When I am stressed out or
emotional, or something is
upsetting me, I tend to smoke
a lot more. A whole lot more.”
8 “Smoking may just be
another coping method and
another way to deal with
the stress, anxiety,
unpleasant feelings…”
Coping
with
cravings
Strength 10 10 “I went for a walk. I exercised
to get my endorphins going
that way and eventually the
cravings went away.”
0
Deficit 13 11 “The craving. The tobacco
companies are geniuses. Like
a mixture that they have is so
addictive and it is so strong
and you do not even have
power over it. It controls you.”
2 “They have to know what
to do with the cravings.”
Coping
with fatigue
Strength 0 0 0
Deficit 13 11 “I have to chain smoke to keep
myself awake.”
2 “[They think] ‘it [the
methadone] makes me
sleepy, so I’ll just smoke.’”
Social skills
Developing
supportive
social
networks
Strength 13 10 “You find ways to get away
from people that smoke. The
more you want it, the more
you’ll find people on your
level.”
3 “…his wife bugged him
enough and he [the client]
quit.”
Deficit 27 18 “Well, everybody, my
boyfriend smokes, my brother
smokes, my mom, my dad,
like everybody smokes. I feel
like smokers cling together.”
9 “I think that most of the
people in their lives
probably smoke as well.”
Saying
“no” to
offered
cigarettes
Strength 0 0 0
Deficit 4 2 “Sometimes, somebody is like,
‘Oh, you want to come and
smoke a cigarette?’ Even if,
like, I just went out and
smoked a cigarette 20 minutes
ago, ‘Alright, let’s go smoke a
cigarette again.’”
2 “…the more you are around
it, the more acceptable, the
less likely you will say
‘no’.”
Negotiating
clinic
culture
Strength 11 11 “It [clinic culture] doesn’t
affect me because I come in,
get my dose, get back in my
car, and I split.”
0
Deficit 21 13 “Instead of saying we’re
taking a 5-minute break, the
counselor would be like
‘We’re taking a 10-minute
smoke break. Basically
because everybody except
maybe one person gets up and
smokes.”
8 “I think among the patients
it is a big culture. The
second there is a break for
group they all rush out and
smoke cigarettes.”
Breaking links and changing routine
Breaking
smoking
links with
alcohol
and coffee
Strength 1 1 “Some people smoke a lot
when they go to a bar or drink.
If I ever drink, I would, like,
have 18 cigarettes left in my
pack.”
0
Deficit 15 13 “Coffee and cigarettes is, like,
the best match…I smoke
another cigarette when the
coffee is still hot and then I
will warm my coffee up and
smoke another cigarette. At
least five cigarettes with my
one coffee.”
2 “…she relapsed on alcohol
and the relapse to alcohol
led her back to cigarette
smoking.”
Breaking
link with
methadone
dosing
Strength 9 6 “When I take methadone, I
can go with or without the
cigarette afterwards.”
3 “I have heard, you know,
people saying that once
they started methadone they
just don’t have a taste for
cigarettes.”
Deficit 21 17 “I think it is more of a
Pavlovian response that, okay,
I got my meth, now I am
having a cigarette.”
4 “Methadone clients smoke
a cigarette after taking a
dose.”
Breaking
link with
drug use
Strength 1 1 “When I did drugs, I definitely
didn’t smoke…cigarettes
definitely weren’t in the
picture.”
0
Deficit 19 13 “Every time I go back to
using, I start smoking again.”
6 “I just believe that tobacco
is just part of the whole
culture of drug use. We
know we have removed the
drugs, the culture remains
and tobacco continues.”
Changing
routine
Strength 2 2 “I found out what worked for
me is by me not having that
cigarette to take the dogs out
or the minute I wake up. I
smoke less.”
0
Deficit 13 8 “It’s like routine…you’re so
used to eating something then
smoking a cigarette…you get
your dose and then you smoke
a cigarette…You’re just so
used to doing the same thing
every day…it takes a while to
break a routine that you have
had for so long.”
5 “I find that in speaking with
smokers, I find that they do
it at certain times. It is
habitual in that way, and I
think it is the same for
clients. ‘I smoke when I get
up in the morning, or I
smoke when I do this. If I
take a break from work, I
will do this.”
Pharmacotherapy
Obtaining
pharmaco-
therapy and
taking
correctly
Strength 15 9 “I tried the inhaler and that
works good. And even now, I
still have some more, and if I
do not have cigarettes, and I
need nicotine, I’ll do the
inhaler.”
6 “I think once they have it
[pharmacotherapy], they
will take it properly.”
Deficit 16 6 “It’s easier to get $20 a day to
get a pack of cigarettes…it is
not so secure in a lot of
people’s heads that ‘I can put
$100 aside for the quit
smoking things.’”
10 “…some of them will have
difficulty following through
and taking the medications
as prescribed.”
Existing skills
Skills used
to quit
drugs
Strength 8 6 “It’s the same thing with
drugs. You’ve got to change
people, places, and things. If
you don’t want to smoke
anymore, you are not going to
hang out at bars. You are not
going to hang out with people
that smoke. You’ve got to
separate yourself. It is just
like, if you want to quit getting
high, you are not going to
hang out with people that are
getting high.”
2 “They have to develop a
concrete plan with people,
places, and things.”
Deficit 1 0 1 “It’s a little different [from
quitting drugs], they change
their phone numbers so the
dealers cannot call them
anymore.”
a

Number of participants who provided comments.

Replacing smoking

Eight of the clients and almost all of the counselors spoke about clients’ need to have a replacement for smoking to feel “good” or “calm” and cope with daily life, generally. Clients reported feeling reluctant to give up cigarettes due to the feeling that “I am already giving up everything else that made me feel good. “

Coping with stress/emotions

Although 4 clients stated that their smoking decreases when anxious or depressed, 13 clients and almost all of the counselors spoke about clients’ reliance on cigarettes to help cope with specific emotions and stress.

Coping with cravings

While only 2 counselors spoke about clients’ ability to cope with cravings (as a deficit), 10 clients described ways in which they have been or are able to cope with cravings to smoke. Clients spoke about resisting cravings by using methods such as going for a walk, exercising, reading, eating a piece of candy, chewing gum, waiting until the urge to smoke passes, and putting cigarettes where they are not easily accessible. In contrast, however, 11 clients talked about their difficulties resisting cravings.

Coping with fatigue

Eleven clients and 2 counselors spoke about clients smoking to help them stay awake or to cope with fatigue, sometimes setting fires when they fall asleep smoking a cigarette.

Negotiating clinic culture

Thirteen clients and 8 counselors described a culture in the methadone clinic that supports smoking and makes smoking abstinence difficult. Clients and counselors reported that socialization among the clients is focused on smoking. In fact, one client described another who came to the clinic on days she wasn’t required to attend just to acquire cigarettes from other clients. However, 11 clients, while acknowledging the smoking culture in the methadone clinic, were able to resist or avoid clinic influences.

Developing supportive social networks

Ten clients spoke about having social contacts supportive of their quitting smoking or an understanding of how to develop social relationships supportive of smoking abstinence. However, 18 clients and 9 counselors described limited social networks among clients that support continued smoking and not smoking abstinence. For example, in one of the client focus groups, when asked if they know of anyone in methadone treatment that quit smoking, all participants said, “No.”

Saying “no.”

A couple of clients and counselors stated that some clients have difficulty “saying no” when offered cigarettes by others, even when they don’t desire a cigarette.

Breaking links with alcohol and coffee

Thirteen clients and 2 counselors stated that smoking is linked with drinking alcohol and coffee. One client stated that “They go one hand on the drink and one hand on a cigarette.”

Breaking link with methadone dosing

Many clients and counselors spoke about the ritual of smoking cigarettes soon after methadone dosing. Clients also reported increased craving after methadone dosing. For example, one client said, “The methadone makes me, like, want to chain smoke, especially right after my dose.”

Breaking link with drug use

One client stated that smoking is not related to his drug use. However, 13 clients and 6 counselors spoke about how smoking and drug use are intimately related. One client who had quit smoking, when asked about what made him start smoking again, said, “Drugs. I just came home and started using again…that [drugs and smoking] goes hand in glove.”

Changing routine

Almost all clients and counselors who spoke about clients’ routines talked about how smoking is integrated into clients’ daily activities, and changing their long standing routines is difficult. One client stated that smoking, to her, is “like getting up and brushing your teeth every morning.”

Obtaining and taking pharmacotherapy

Nine clients spoke about successfully obtaining and using at least one smoking cessation medication; however, six reported that clients have difficulty obtaining smoking cessation pharmacotherapy due to lack of financial resources or difficulty budgeting their money. All of the counselors expressed concerns about clients’ ability to afford and obtain medications to help them stop smoking, and 4 counselors believed that clients may have difficulty taking the medication correctly, if they are able to obtain it. The counselors stated that clients may have difficulty taking smoking cessation pharmacotherapy because they may 1) not understand dosing directions, 2) have trouble obtaining prescription renewals, 3) lose the medication, 4) forget doses, and 5) struggle with side effects.

Applying existing skills

Six clients and 2 counselors described how clients are able to apply skills acquired when quitting drugs, to quitting smoking. For example, clients learned to identify and avoid “people, places, and things” associated with drug use, and, when quitting smoking need to identify and avoid “people, places, and things” associated with smoking.

Discussion

This study explored the information, motivation, and behavioral skills that are relevant for treating tobacco dependence among smokers in methadone treatment. Information, motivation, and behavioral skills factors known to impact smokers trying to quit in the general population were described as also relevant for methadone maintained smokers (Table 4; Bansal, et al., 2004; Biener, et al., 2007; Hyland, et al., 2006; Li, et al., 2010; Li, et al., 2011; Schauer, et al., 2013; Vogt, et al., 2008; Zhu, et al., 2002). However, information, motivation, and behavioral skills factors specific to methadone maintained smokers were also described (Table 4), and specific information, motivation, and behavioral skills strengths and deficits varied by individual clients.

Table 4.

Summary of IMB factors relevant to smoking cessation among methadone maintained smokers

Factors Relevant to
the General Population
Factors Specific to
Methadone Maintained Smokers
Information Health effects of smoking The relationship between quitting
smoking and drug relapse
Toxins in cigarettes
Pharmacotherapy
Smoking cessation counseling
resources
Motivators/Barriers
to Motivation
Pregnancy/Children Belief that smoking is the same as
using drugs
Cost of smoking Feeling that it is too much to quit
smoking and drugs at the same time
Health
Smell of smoke
Enjoyment of smoking
Concern about weight gain
Cost of treatment
Social pressure to smoke
Behavioral Skills Replacing smoking Negotiating clinic culture
Coping with emotions/stress Breaking link with methadone
dosing
Coping with fatigue Breaking link with drug use
Developing supportive social
networks
Skills used to quit drugs
Saying “no” to offered cigarettes
Breaking links with alcohol and
coffee
Changing routine
Obtaining pharmacotherapy and
taking correctly

The information topics noted to be relevant for methadone maintained smokers included health, treatment, and drug relapse risk. Knowledge about how smoking impacts health, pharmacotherapy options, and resources for smoking cessation counseling are known to facilitate quitting among smokers in the general population (Bansal, et al., 2004; Biener, et al., 2007; Hyland, et al., 2006; Li, et al., 2010; Li, et al., 2011; Schauer, et al., 2013; Vogt, et al., 2008; Zhu, et al., 2002). Although some clients in methadone treatment fear that quitting smoking may lead to drug relapse, research shows that quitting smoking while in drug treatment supports abstinence from drugs (Lemon, Friedmann, & Stein, 2003; Prochaska, Delucchi, & Hall, 2004). Educating smokers in methadone treatment who lack awareness about the health effects of smoking, toxins in cigarettes, smoking cessation treatment, or the relationship between smoking cessation and drug relapse could motivate some of those smokers to make a quit attempt.

Some clients expressed motivation or confidence in ability to quit smoking; however, more expressed lack of motivation, ambivalence, or low confidence in ability to quit smoking, a finding that is supported by previous research (Bowman et al., 2012; Clemmey, Brooner, Chutuape, Kidorf, & Stitzer, 1997; Nahvi, et al., 2006). Motivation and self-efficacy for smoking cessation are known to be related to quit attempts (Borland, et al., 2010), and self-efficacy for quitting has been found to be related to smoking abstinence duration in a smoking cessation treatment clinical trial among methadone maintained smokers, specifically (Stein, Anderson, & Niaura, 2007). Although motivation and self-efficacy clearly need to be addressed to increase smoking abstinence among methadone maintained smokers, a clinical trial of a tailored motivational intervention among smokers in methadone treatment found that the motivational intervention was minimally effective (Stein, Weinstock, et al., 2006). Barriers to smoking cessation motivation and confidence need to be further researched among methadone maintained smokers to develop better interventions for increasing motivation and self-efficacy in this population.

Participants described specific smoking cessation motivators and barriers to motivation, some of which have been found to apply to the general population, such as pregnancy or children, cost of smoking, health, the smell of smoke, enjoyment of smoking, concern about weight gain, and cost of treatment (Aubin, Berlin, Smadja, & West, 2009; Baha & Le Faou, 2010; Berg, Park, Chang, & Rigotti, 2008; Borland, et al., 2010; Fidler & West, 2009, 2011; Gallus et al., 2013; Gross et al., 2008; Krist et al., 2010; Li, et al., 2010; Li, et al., 2011; Luostarinen et al., 2013; Pletsch & Kratz, 2004; Roddy, Antoniak, Britton, Molyneux, & Lewis, 2006; Rosenthal et al., 2013; Yong & Borland, 2008). Some clients were motivated to quit by the belief that smoking is the same as other drug use; however, participants also described the feeling that it is too much to quit smoking and drugs at the same time. Studies of methadone maintained smokers and substance abuse treatment staff have previously reported concerns that quitting smoking and drugs at the same time could be “too much” to focus on at one time (Richter, Hunt, Cupertino, Garrett, & Friedmann, 2012; Richter, McCool, Okuyemi, Mayo, & Ahluwalia, 2002). Participants also described social pressures that negatively impact clients’ motivation to quit smoking. These findings replicate previous studies that have found that individuals in methadone treatment have social networks and a clinic environment that make smoking cessation difficult (McCool, Richter, & Choi, 2005; Richter, McCool, et al., 2002). Given these findings, methadone maintained smokers may benefit from an intervention that incorporates: 1) discussion about the relative importance of smoking enjoyment versus other potential motivators, 2) education about weight gain potential and strategies for minimizing weight gain, 3) education about treatment cost, insurance coverage, and access to low cost treatment, 4) financial management to decrease treatment cost burden, 5) education about the association between quitting smoking and drug abstinence, 6) discussion of smoking cessation timing relative to drug abstinence stability, and 7) resources for smoking cessation support. Further, individually tailoring a smoking cessation intervention to identify and discuss the motivators and barriers to motivation that are most important relative to smoking for the individual smoker in methadone treatment could also improve treatment outcomes. Further research on how addressing these motivators and barriers to motivation impacts quit attempts among smokers in methadone treatment is necessary.

Five categories of behavioral skills were described as applicable to smoking cessation in methadone maintained smokers: 1) coping skills, 2) social skills, 3) breaking links and changing routine, 4) taking and obtaining pharmacotherapy, and 5) applying existing skills. In this study, smoking was described as the only or primary means of coping with stress, emotions, and daily life for many smokers in methadone treatment. However, studies have found that smoking can increase anxiety and stress levels and that quitting smoking can decrease negative emotions and stress (Taylor et al., 2014). Also, clients and counselors reported that individuals in methadone treatment use smoking to cope with fatigue, often leading to burning furniture or themselves, and this finding is supported by other research among methadone maintained smokers (Richter, McCool, et al., 2002). Many clients reported difficulty coping with nicotine cravings; however, almost as many clients spoke about using effective and healthy methods for coping with cravings and resisting the urge to smoke. These findings suggest that research is needed on an IMB smoking cessation intervention for smokers in methadone treatment that 1) helps clients develop healthy coping skills to deal with emotions and stress, 2) educates clients about the relationship between negative emotions and smoking, 3) helps clients develop healthy sleep patterns to avoid fatigue, 4) incorporate harm reductions strategies for clients who continue to smoke (to avoid fires and burns when fatigued), 5) teaches clients, who need them, skills to deal with cravings, and 6) facilitates healthy coping skill implementation among the many clients who have them..

A large number of clients and a few counselors noted social skill strengths among clients. However, the majority of participants described social networks and clinical environments that are supportive of continued smoking. Further, participants stated that clients have difficulty saying “no” to offered cigarettes. People with opiate dependence are known to have difficulties with interpersonal skills that could better help them to resist the temptations of their social and treatment environments (Lindquist, Lindsay, & White, 1979). Therefore, an intervention that includes options for helping clients develop skills to better negotiate social interactions and social triggers could help support smoking abstinence in methadone maintained smokers. Smoking cessation treatment that includes discussion of relying on existing social relationships supportive of smoking abstinence and utilizing existing social skills to negotiate social triggers, among the smokers who have such networks and skills, could also help smokers in this population quit.

Smokers in our study, similar to smokers in the general population, paired cigarette smoking with coffee or alcohol, and integrated smoking into numerous aspects of their daily routines (Perkins, Fonte, Ashcom, Broge, & Wilson, 2001; Swanson, Lee, & Hopp, 1994). Participants also reported links between methadone dosing and smoking behavior and illicit drug use and smoking behavior. Previous studies have found a significant positive associations between methadone dose level/timing and smoking behavior and illicit drug use and smoking (Richter et al., 2007; Stein & Anderson, 2003). Further, laboratory studies have found that nicotine increases methadone self-administration, and the pleasurable effects of methadone are enhanced when nicotine is administered (Elkader, Brands, Selby, & Sproule, 2009; Spiga, Schmitz, & Day, 1998). More research on the interactions between opiates and nicotine are necessary to better understand their simultaneous use and to better tailor interventions for smokers in methadone treatment. Smoking cessation treatment for methadone maintained smokers could support smoking abstinence by incorporating skill building options for breaking the links between smoking and other behaviors that the clients may not be ready to change, changing daily routines or routines associated with methadone dosing or drug use, or coping with increased tobacco craving related to methadone dosing.

Clients and counselors also described skill strengths and deficits related to obtaining and correctly taking smoking cessation pharmacotherapy and applying skills used to quit drugs. Proper adherence to smoking cessation pharmacotherapy is known to be low, even in general population samples of smokers, due to issues such as difficulty remembering to take the medication, managing side-effects, and following dosing instructions (Balmford, Borland, Hammond, & Cummings, 2011; Catz, et al., 2011; de Dios, Anderson, Stanton, Audet, & Stein, 2012; Etter & Schneider, 2013; Grassi et al., 2011; Hays, Leischow, Lawrence, & Lee, 2010; Lee et al., 2012; Liberman et al., 2013; Swan et al., 2010). Smoking cessation treatment clinical trials among methadone maintained smokers, specifically, have shown poor adherence to smoking cessation pharmacotherapy, and that pharmacotherapy adherence is related to smoking cessation outcomes (Richter, et al., 2005; Stein, Anderson, & Niaura, 2006; Stein, et al., 2013). Also, smokers in methadone treatment who have successfully quit using drugs have skills that can be applied to quitting smoking. Therefore, research is needed on an IMB-based smoking cessation intervention that includes skill building options for 1) managing finances to obtain pharmacotherapy, 2) communicating with physicians to obtain prescriptions, 3) remembering to take smoking cessation pharmacotherapy, as instructed, 4) managing side-effects, and 5) applying skills already obtained when quitting drugs to quitting smoking.

This study has some limitations. The sample only included English-speaking clients and counselors who volunteered to participate at two methadone clinics in New Jersey, limiting generalizability. We also did not have information on the tobacco or drug use history of the counselors, and this history could have influenced their responses. Further, given this was a qualitative study, the results are only participants’ perceptions of the information, motivation, and behavioral skills related to smoking cessation among clients in methadone treatment. Future quantitative research is needed to determine if the information, motivation, and behavior skills noted to be relevant in this study is significantly related to smoking cessation in methadone maintained smokers.

This study provides a foundation for developing an intervention that addresses the unique issues of methadone maintained smokers and also incorporates attention to the issues that are relevant to smokers, in general. To address the information, motivation, and behavioral skills deficits found to be relevant in this study, a newly developed intervention may include a combination of or options for counselors to use education, motivational interviewing, and cognitive behavioral skills training to address the issues unique to each individual smoker in methadone treatment.

Acknowledgments

This work was funded by the National Institute on Drug Abuse (K23DA025049). The authors thank Donna Drummond, the staff and clients at the New Brunswick Counseling Center, and the staff and clients at New Horizon Treatment Services for their help implementing this study.

Contributor Information

Nina A. Cooperman, Division of Addiction Psychiatry, Rutgers Robert Wood Johnson Medical School

Kimber P. Richter, Department of Preventive Medicine and Public Health, University of Kansas Medical Center

Steven L. Bernstein, Department of Emergency Medicine, Yale School of Medicine

Marc L. Steinberg, Division of Addiction Psychiatry, Rutgers Robert Wood Johnson Medical School

Jill M. Williams, Division of Addiction Psychiatry, Rutgers Robert Wood Johnson Medical School

References

  1. Aubin HJ, Berlin I, Smadja E, West R. Factors associated with higher body mass index, weight concern, and weight gain in a multinational cohort study of smokers intending to quit. Int J Environ Res Public Health. 2009;6(3):943–957. doi: 10.3390/ijerph6030943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Axelrod S. Smoking cessation through functional analysis. J Appl Behav Anal. 1991;24(4):717–718. doi: 10.1901/jaba.1991.24-717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baha M, Le Faou AL. Smokers’ reasons for quitting in an anti-smoking social context. Public Health. 2010;124(4):225–231. doi: 10.1016/j.puhe.2010.02.011. [DOI] [PubMed] [Google Scholar]
  4. Balmford J, Borland R, Hammond D, Cummings KM. Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey. Nicotine Tob Res. 2011;13(2):94–102. doi: 10.1093/ntr/ntq215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bansal MA, Cummings KM, Hyland A, Giovino GA. Stop-smoking medications: who uses them, who misuses them, and who is misinformed about them? Nicotine Tob Res. 2004;6(Suppl 3):S303–s310. doi: 10.1080/14622200412331320707. [DOI] [PubMed] [Google Scholar]
  6. Berg CJ, Park ER, Chang Y, Rigotti NA. Is concern about post-cessation weight gain a barrier to smoking cessation among pregnant women? Nicotine Tob Res. 2008;10(7):1159–1163. doi: 10.1080/14622200802163068. [DOI] [PubMed] [Google Scholar]
  7. Biener L, Bogen K, Connolly G. Impact of corrective health information on consumers’ perceptions of “reduced exposure” tobacco products. Tob Control. 2007;16(5):306–311. doi: 10.1136/tc.2006.019240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Borland R, Yong HH, Balmford J, Cooper J, Cummings KM, O’Connor RJ, et al. Motivational factors predict quit attempts but not maintenance of smoking cessation: findings from the International Tobacco Control Four country project. Nicotine Tob Res. 2010;12(Suppl):S4–S11. doi: 10.1093/ntr/ntq050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bowman J, Wiggers J, Colyvas K, Wye P, Walsh RA, Bartlem K. Smoking cessation among Australian methadone clients: prevalence, characteristics and a need for action. Drug Alcohol Rev. 2012;31(4):507–513. doi: 10.1111/j.1465-3362.2011.00408.x. [DOI] [PubMed] [Google Scholar]
  10. Campbell BK, Wander N, Stark MJ, Holbert T. Treating cigarette smoking in drug-abusing clients. J Subst Abuse Treat. 1995;12(2):89–94. doi: 10.1016/0740-5472(95)00002-m. [DOI] [PubMed] [Google Scholar]
  11. Catz SL, Jack LM, McClure JB, Javitz HS, Deprey M, Zbikowski SM, et al. Adherence to varenicline in the COMPASS smoking cessation intervention trial. Nicotine Tob Res. 2011;13(5):361–368. doi: 10.1093/ntr/ntr003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Clemmey P, Brooner R, Chutuape MA, Kidorf M, Stitzer M. Smoking habits and attitudes in a methadone maintenance treatment population. Drug Alcohol Depend. 1997;44(2–3):123–132. doi: 10.1016/s0376-8716(96)01331-2. [DOI] [PubMed] [Google Scholar]
  13. Cook BL, Wayne GF, Kafali EN, Liu Z, Shu C, Flores M. Trends in smoking among adults with mental illness and association between mental health treatment and smoking cessation. JAMA. 2014;311(2):172–182. doi: 10.1001/jama.2013.284985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Cooperman NA, Parsons JP, Chabon B, Berg KM, Arnsten JH. The development and feasibility of an intervention to improve antiretroviral adherence among HIV-positive patients receiving primary-care in methadone clinics. Journal of HIV/AIDS and Social Services. 2007;6(1/2):101–120. [Google Scholar]
  15. de Dios MA, Anderson BJ, Stanton C, Audet DA, Stein M. Project Impact: a pharmacotherapy pilot trial investigating the abstinence and treatment adherence of Latino light smokers. J Subst Abuse Treat. 2012;43(3):322–330. doi: 10.1016/j.jsat.2012.01.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Elkader AK, Brands B, Selby P, Sproule BA. Methadone-nicotine interactions in methadone maintenance treatment patients. J Clin Psychopharmacol. 2009;29(3):231–238. doi: 10.1097/JCP.0b013e3181a39113. [DOI] [PubMed] [Google Scholar]
  17. Elo S, Kyngas H. The qualitative content analysis process. J Adv Nurs. 2008;62(1):107–115. doi: 10.1111/j.1365-2648.2007.04569.x. [DOI] [PubMed] [Google Scholar]
  18. Etter JF, Schneider NG. An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion. Nicotine Tob Res. 2013;15(1):59–68. doi: 10.1093/ntr/nts084. [DOI] [PubMed] [Google Scholar]
  19. Ferguson SG, Shiffman S. The relevance and treatment of cue-induced cravings in tobacco dependence. J Subst Abuse Treat. 2009;36(3):235–243. doi: 10.1016/j.jsat.2008.06.005. [DOI] [PubMed] [Google Scholar]
  20. Fidler JA, West R. Self-perceived smoking motives and their correlates in a general population sample. Nicotine Tob Res. 2009;11(10):1182–1188. doi: 10.1093/ntr/ntp120. [DOI] [PubMed] [Google Scholar]
  21. Fidler JA, West R. Enjoyment of smoking and urges to smoke as predictors of attempts and success of attempts to stop smoking: a longitudinal study. Drug Alcohol Depend. 2011;115(1–2):30–34. doi: 10.1016/j.drugalcdep.2010.10.009. [DOI] [PubMed] [Google Scholar]
  22. Fisher WA, Fisher JD, Harman J. The Information-Motivation-Behavioral Skills Model: A general social psychological approach to understanding and promoting health behavior. In: Suls J, editor. Social Psychological Foundations of Health and Illness. Malden, MA: Blackwell Publishing; 2009. pp. 82–106. [Google Scholar]
  23. Gallus S, Muttarak R, Franchi M, Pacifici R, Colombo P, Boffetta P, et al. Why do smokers quit? Eur J Cancer Prev. 2013;22(1):96–101. doi: 10.1097/CEJ.0b013e3283552da8. [DOI] [PubMed] [Google Scholar]
  24. Glaser BG, Strauss AL. Discovery of Grounded Theory: Strategies for Qualitative Research. Chicago: Aldine; 1967. [Google Scholar]
  25. Grassi MC, Enea D, Ferketich AK, Lu B, Pasquariello S, Nencini P. Effectiveness of varenicline for smoking cessation: a 1-year follow-up study. J Subst Abuse Treat. 2011;41(1):64–70. doi: 10.1016/j.jsat.2011.01.014. [DOI] [PubMed] [Google Scholar]
  26. Gross B, Brose L, Schumann A, Ulbricht S, Meyer C, Volzke H, et al. Reasons for not using smoking cessation aids. BMC Public Health. 2008;8:129. doi: 10.1186/1471-2458-8-129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Hays JT, Leischow SJ, Lawrence D, Lee TC. Adherence to treatment for tobacco dependence: association with smoking abstinence and predictors of adherence. Nicotine Tob Res. 2010;12(6):574–581. doi: 10.1093/ntr/ntq047. [DOI] [PubMed] [Google Scholar]
  28. Hurt RD, Offord KP, Croghan IT, Gomez-Dahl L, Kottke TE, Morse RM, et al. Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA. 1996;275(14):1097–1103. doi: 10.1001/jama.275.14.1097. [DOI] [PubMed] [Google Scholar]
  29. Hyland A, Borland R, Li Q, Yong HH, McNeill A, Fong GT, et al. Individual-level predictors of cessation behaviours among participants in the International Tobacco Control (ITC) Four Country Survey. Tob Control. 2006;15(Suppl 3):ii83–ii94. doi: 10.1136/tc.2005.013516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kennett DJ, Morris E, Bangs AM. Learned resourcefulness and smoking cessation revisited. Patient Educ Couns. 2006;60(2):206–211. doi: 10.1016/j.pec.2005.01.005. [DOI] [PubMed] [Google Scholar]
  31. Krist AH, Woolf SH, Johnson RE, Rothemich SF, Cunningham TD, Jones RM, et al. Patient costs as a barrier to intensive health behavior counseling. Am J Prev Med. 2010;38(3):344–348. doi: 10.1016/j.amepre.2009.11.010. [DOI] [PubMed] [Google Scholar]
  32. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–174. [PubMed] [Google Scholar]
  33. Lawhon D, Humfleet GL, Hall SM, Munoz RF, Reus VI. Longitudinal analysis of abstinence-specific social support and smoking cessation. Health Psychol. 2009;28(4):465–472. doi: 10.1037/a0015206. [DOI] [PubMed] [Google Scholar]
  34. Lee JY, Kim MJ, Jun HJ, Kang M, Park AR, Oh DE, et al. Adherence to varenicline and abstinence rates for quitting smoking in a private health promotion center-based smoking cessation clinic. Tuberc Respir Dis (Seoul) 2012;72(5):426–432. doi: 10.4046/trd.2012.72.5.426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Lemon SC, Friedmann PD, Stein MD. The impact of smoking cessation on drug abuse treatment outcome. Addict Behav. 2003;28(7):1323–1331. doi: 10.1016/s0306-4603(02)00259-9. [DOI] [PubMed] [Google Scholar]
  36. Li L, Borland R, Yong HH, Fong GT, Bansal-Travers M, Quah AC, et al. Predictors of smoking cessation among adult smokers in Malaysia and Thailand: findings from the International Tobacco Control Southeast Asia Survey. Nicotine Tob Res. 2010;12(Suppl):S34–S44. doi: 10.1093/ntr/ntq030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Li L, Feng G, Jiang Y, Yong HH, Borland R, Fong GT. Prospective predictors of quitting behaviours among adult smokers in six cities in China: findings from the International Tobacco Control (ITC) China Survey. Addiction. 2011;106(7):1335–1345. doi: 10.1111/j.1360-0443.2011.03444.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Liberman JN, Lichtenfeld MJ, Galaznik A, Mastey V, Harnett J, Zou KH, et al. Adherence to varenicline and associated smoking cessation in a community-based patient setting. J Manag Care Pharm. 2013;19(2):125–131. doi: 10.18553/jmcp.2013.19.2.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Lindquist CU, Lindsay JS, White GD. Assessment of assertiveness in drug abusers. J Clin Psychol. 1979;35(3):676–679. doi: 10.1002/1097-4679(197907)35:3<676::aid-jclp2270350336>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  40. Luostarinen M, Tuovinen EL, Saarni SE, Kinnunen T, Hukkinen M, Haukkala A, et al. Weight concerns among Finnish ever-smokers: a population-based study. Nicotine Tob Res. 2013;15(10):1696–1704. doi: 10.1093/ntr/ntt043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. McCaul KD, Hockemeyer JR, Johnson RJ, Zetocha K, Quinlan K, Glasgow RE. Motivation to quit using cigarettes: a review. Addict Behav. 2006;31(1):42–56. doi: 10.1016/j.addbeh.2005.04.004. [DOI] [PubMed] [Google Scholar]
  42. McCool RM, Richter KP, Choi WS. Benefits of and barriers to providing smoking treatment in methadone clinics: findings from a national study. Am J Addict. 2005;14(4):358–366. doi: 10.1080/10550490591003693. [DOI] [PubMed] [Google Scholar]
  43. Nahvi S, Ning Y, Segal KS, Richter KP, Arnsten JH. Varenicline efficacy and safety among methadone maintained smokers: a randomized placebo-controlled trial. Addiction. 2014 doi: 10.1111/add.12631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Nahvi S, Richter K, Li X, Modali L, Arnsten J. Cigarette smoking and interest in quitting in methadone maintenance patients. Addict Behav. 2006;31(11):2127–2134. doi: 10.1016/j.addbeh.2006.01.006. [DOI] [PubMed] [Google Scholar]
  45. Perkins KA, Fonte C, Ashcom J, Broge M, Wilson A. Subjective responses to nicotine in smokers may be associated with responses to caffeine and to alcohol. Exp Clin Psychopharmacol. 2001;9(1):91–100. doi: 10.1037/1064-1297.9.1.91. [DOI] [PubMed] [Google Scholar]
  46. Pletsch PK, Kratz AT. Why do women stop smoking during pregnancy? Cigarettes taste and smell bad. Health Care Women Int. 2004;25(7):671–679. doi: 10.1080/07399330490458051. [DOI] [PubMed] [Google Scholar]
  47. Prochaska JJ, Delucchi K, Hall SM. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. J Consult Clin Psychol. 2004;72(6):1144–1156. doi: 10.1037/0022-006X.72.6.1144. [DOI] [PubMed] [Google Scholar]
  48. Reid MS, Fallon B, Sonne S, Flammino F, Nunes EV, Jiang H, et al. Smoking cessation treatment in community-based substance abuse rehabilitation programs. J Subst Abuse Treat. 2008;35(1):68–77. doi: 10.1016/j.jsat.2007.08.010. [DOI] [PubMed] [Google Scholar]
  49. Richter KP, Ahluwalia HK, Mosier MC, Nazir N, Ahluwalia JS. A population-based study of cigarette smoking among illicit drug users in the United States. Addiction. 2002;97(7):861–869. doi: 10.1046/j.1360-0443.2002.00162.x. [DOI] [PubMed] [Google Scholar]
  50. Richter KP, Arnsten JH. A rationale and model for addressing tobacco dependence in substance abuse treatment. Subst Abuse Treat Prev Policy. 2006;1:23. doi: 10.1186/1747-597X-1-23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Richter KP, Choi WS, McCool RM, Harris KJ, Ahluwalia JS. Smoking cessation services in U.S. methadone maintenance facilities. Psychiatr Serv. 2004;55(11):1258–1264. doi: 10.1176/appi.ps.55.11.1258. [DOI] [PubMed] [Google Scholar]
  52. Richter KP, Hamilton AK, Hall S, Catley D, Cox LS, Grobe J. Patterns of smoking and methadone dose in drug treatment patients. Exp Clin Psychopharmacol. 2007;15(2):144–153. doi: 10.1037/1064-1297.15.2.144. [DOI] [PubMed] [Google Scholar]
  53. Richter KP, Hunt JJ, Cupertino AP, Garrett S, Friedmann PD. Understanding the drug treatment community’s ambivalence towards tobacco use and treatment. Int J Drug Policy. 2012;23(3):220–228. doi: 10.1016/j.drugpo.2011.11.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Richter KP, McCool RM, Catley D, Hall M, Ahluwalia JS. Dual pharmacotherapy and motivational interviewing for tobacco dependence among drug treatment patients. J Addict Dis. 2005;24(4):79–90. doi: 10.1300/j069v24n04_06. [DOI] [PubMed] [Google Scholar]
  55. Richter KP, McCool RM, Okuyemi KS, Mayo MS, Ahluwalia JS. Patients’ views on smoking cessation and tobacco harm reduction during drug treatment. Nicotine Tob Res. 2002;4(Suppl 2):S175–S182. doi: 10.1080/1462220021000032735. [DOI] [PubMed] [Google Scholar]
  56. Roddy E, Antoniak M, Britton J, Molyneux A, Lewis S. Barriers and motivators to gaining access to smoking cessation services amongst deprived smokers--a qualitative study. BMC Health Serv Res. 2006;6:147. doi: 10.1186/1472-6963-6-147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Rosenthal L, Carroll-Scott A, Earnshaw VA, Sackey N, O’Malley SS, Santilli A, et al. Targeting cessation: understanding barriers and motivations to quitting among urban adult daily tobacco smokers. Addict Behav. 2013;38(3):1639–1642. doi: 10.1016/j.addbeh.2012.09.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Schauer GL, Malarcher AM, Zhang L, Engstrom MC, Zhu SH. Prevalence and Correlates of Quitline Awareness and Utilization in the United States: An Update From the 2009-2010 National Adult Tobacco Survey. Nicotine Tob Res. 2013 doi: 10.1093/ntr/ntt181. [DOI] [PubMed] [Google Scholar]
  59. Schmitz JM, Grabowski J, Rhoades H. The effects of high and low doses of methadone on cigarette smoking. Drug Alcohol Depend. 1994;34(3):237–242. doi: 10.1016/0376-8716(94)90162-7. [DOI] [PubMed] [Google Scholar]
  60. Shoptaw S, Rotheram-Fuller E, Yang X, Frosch D, Nahom D, Jarvik ME, et al. Smoking cessation in methadone maintenance. Addiction. 2002;97(10):1317–1328. doi: 10.1046/j.1360-0443.2002.00221.x. discussion 1325. [DOI] [PubMed] [Google Scholar]
  61. Spiga R, Schmitz J, Day J., 2nd Effects of nicotine on methadone self-administration in humans. Drug Alcohol Depend. 1998;50(2):157–165. doi: 10.1016/s0376-8716(98)00020-9. [DOI] [PubMed] [Google Scholar]
  62. Stein MD, Anderson BJ. Nicotine and drug interaction expectancies among methadone maintained cigarette smokers. J Subst Abuse Treat. 2003;24(4):357–361. doi: 10.1016/s0740-5472(03)00030-8. [DOI] [PubMed] [Google Scholar]
  63. Stein MD, Anderson BJ, Niaura R. Nicotine replacement therapy: patterns of use after a quit attempt among methadone-maintained smokers. J Gen Intern Med. 2006;21(7):753–757. doi: 10.1111/j.1525-1497.2006.00504.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Stein MD, Anderson BJ, Niaura R. Smoking cessation patterns in methadone-maintained smokers. Nicotine Tob Res. 2007;9(3):421–428. doi: 10.1080/14622200701188885. [DOI] [PubMed] [Google Scholar]
  65. Stein MD, Caviness CM, Kurth ME, Audet D, Olson J, Anderson BJ. Varenicline for smoking cessation among methadone-maintained smokers: a randomized clinical trial. Drug Alcohol Depend. 2013;133(2):486–493. doi: 10.1016/j.drugalcdep.2013.07.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Stein MD, Weinstock MC, Herman DS, Anderson BJ, Anthony JL, Niaura R. A smoking cessation intervention for the methadone-maintained. Addiction. 2006;101(4):599–607. doi: 10.1111/j.1360-0443.2006.01406.x. [DOI] [PubMed] [Google Scholar]
  67. Strauss A, Corbin J. Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory. Thousand Oaks, CA: Sage Publications, Inc.; 1998. [Google Scholar]
  68. Swan GE, McClure JB, Jack LM, Zbikowski SM, Javitz HS, Catz SL, et al. Behavioral counseling and varenicline treatment for smoking cessation. Am J Prev Med. 2010;38(5):482–490. doi: 10.1016/j.amepre.2010.01.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Swanson JA, Lee JW, Hopp JW. Caffeine and nicotine: a review of their joint use and possible interactive effects in tobacco withdrawal. Addict Behav. 1994;19(3):229–256. doi: 10.1016/0306-4603(94)90027-2. [DOI] [PubMed] [Google Scholar]
  70. Taylor G, McNeill A, Girling A, Farley A, Lindson-Hawley N, Aveyard P. Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ. 2014;348:g1151. doi: 10.1136/bmj.g1151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Tsourtos G, O’Dwyer L. Stress, stress management, smoking prevalence and quit rates in a disadvantaged area: has anything changed? Health Promot J Austr. 2008;19(1):40–44. doi: 10.1071/he08040. [DOI] [PubMed] [Google Scholar]
  72. Vogt F, Hall S, Marteau TM. Understanding why smokers do not want to use nicotine dependence medications to stop smoking: qualitative and quantitative studies. Nicotine Tob Res. 2008;10(8):1405–1413. doi: 10.1080/14622200802239280. [DOI] [PubMed] [Google Scholar]
  73. Yong HH, Borland R. Functional beliefs about smoking and quitting activity among adult smokers in four countries: findings from the International Tobacco Control Four-Country Survey. Health Psychol. 2008;27(3 Suppl):S216–S223. doi: 10.1037/0278-6133.27.3(suppl.).s216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Zhu SH, Anderson CM, Tedeschi GJ, Rosbrook B, Johnson CE, Byrd M, et al. Evidence of real-world effectiveness of a telephone quitline for smokers. N Engl J Med. 2002;347(14):1087–1093. doi: 10.1056/NEJMsa020660. [DOI] [PubMed] [Google Scholar]

RESOURCES